About Prenatal and Newborn Genetic Testing
Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can reduce a couple's uncertainty or help them decide whether to abort a pregnancy in case of conditions such as Down syndrome, trisomy 18, or an open neural tube defect. The procedure includes two blood tests: one in the first trimester and the next in the second trimester. On the other hand, newborn genetic testing is done just after birth to identify genetic disorders.
The Global Prenatal and Newborn Genetic Testing market to grow at a CAGR of 31.91 percent over the period 2014-2019.
Read more details at: http://www.bigmarketresearch.com/global-prenatal-and-newborn-genetic-testing-2015-2019-market
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Prenatal and Newborn Genetic Testing market for the period 2015-2019. The Global Prenatal and Newborn Genetic Testing market can be divided into two segments: Diagnostic Techniques and Screening Methods. To calculate the market size, the report considers revenue generated from these segments.
The Global Prenatal and Newborn Genetic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Prenatal and Newborn Genetic Testing market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• APAC
• EMEA
Key Vendors
• Agilent Technologies
• Bio-Rad Laboratories
• Illumina
• Sequenom
Market Driver
• Growing Incidences of Fetal Health-related Abnormalities
• For a full, detailed list, view our report
Market Challenge
• Decrease in Fertility Rates
• For a full, detailed list, view our...